Abstract
Reduced central serotonergic activity has been implicated in poor impulse regulation and aggressive behaviour in animals, adults and also young children.1,2 Two recently published studies have implicated variation at a polymorphism in the promoter of the serotonin transporter (5HTT; hSERT) in influencing susceptibility to ADHD.3,4 Consistent with these results we have also found a trend for the long allele of the promoter polymorphism to influence susceptibility to ADHD in a sample of 113 ADHD parent proband trios (65 transmissions vs 49 non-transmissions, χ2 = 2.25, P = 0.13). A pooled analysis of our, and these published results demonstrated a significant over representation of the long allele of the promoter in ADHD probands compared to controls (χ2 = 7.14, P = 0.008). We have also examined two other 5HTT polymorphisms (the VNTR in intron 2 and the 3′ UTR SNP). TDT analysis demonstrated preferential transmission of the T allele of the 3′ UTR SNP (χ2 = 4.06, P = 0.04). In addition, ETDT analysis of haplotypes demonstrated significant preferential transmission of haplotypes containing the T allele of the 3′ UTR SNP with the long allele of the promoter polymorphism (χ2 = 13.18, 3 df, P = 0.004) and the 10 repeat of the VNTR (χ2 = 8.77, 3 df, P = 0.03). This study provides further evidence for the possible involvement of the serotonin transporter in susceptibility to ADHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH et al. Age related changes in the association between serotonin function and aggression in boys with ADHD Biol Psychiatry 1997; 41: 682–689
Lucki I . The spectrum of behaviors influenced by serotonin Biol Psychiatry 1998; 44: 151–162
Seeger G, Schloss P, Schmidt MH . Functional polymorphism within the promoter of the serotonin transporter gene is associated with severe hyperkinetic disorders Mol Psychiatry 2001; 6: 235–238
Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein RP et al. Family based association study of the serotonin transporter promoter region polymorphism (5HTTLPR) in attention deficit hyperactivity disorder Am J Med Gen 2001; 105: 91–95
Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP . Attention-deficit hyperactivity disorder and hyperkinetic disorder Lancet 1998; 351: 429–433
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV) American Psychiatric Association Press: Washington DC 1994
Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples Arch Gen Psychiatry 1992; 49: 728–738
Thapar A, Holmes J, Poulton K, Harrington R . Genetic basis of attention deficit and hyperactivity Br J Psychiatry 1999; 174: 105–111
Giros JJ, Jaber M, Jones SR, Wightman KM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996; 379: 606–612
Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG . Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 1999; 283: 397–401
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression J Neurochem 1996; 66: 2621–2624
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL . Organisation of the human serotonin transporter gene J Neural Transm 1994; 95: 157–162
Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression Lancet 1996; 347: 731–733
Battersby S, Ogilvie A, Blackwood DHR, Shen S, Muqit MMK, Muir WJ et al. Presence of multiple polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene J Neurochem 1999; 72: 1384–1388
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996; 274: 1527–1531
McKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo Proc Natl Acad Sci USA 1999; 96: 15251–15255
Coyle N, Jones I, Robertson E, Lendon C, Craddock N . Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis Lancet 2000; 356: 1490–1491
Falconer DS . Introduction to Quantitative Genetics John Wiley & Sons: New York, NY 1989
Spielman KS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993; 52: 506–516
Sham PC, Curtis D . An extended transmission/disequilibrium test (TDT) for multi-allele marker loci Ann Hum Genet 1995; 59: 323–336
Dudbridge F, Koeleman BPC, Todd JA, Clayton DG . Unbiased application of the transmission/disequilibrium test to multilocus haplotypes Am J Hum Genet 2000; 66: 2009–2012
Faulk CT, Rubenstein P . Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations Ann Hum Genet, 1987; 51: 227–233
Woolf B . On estimating the relation between blood group and disease Ann Hum Genet 1955; 19: 251–253
World Health Organisation. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research WHO: Geneva 1993
Angold A, Prendergast A, Cox R, Harrington E, Simonoff E, Rutter M . The Child and Adolescent Psychiatric Assessment (CAPA) Psychol Med 1995; 25: 739–753
Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 1999; 4: 192–196
Acknowledgements
LK is a Wellcome Trust Training Fellow in Mental Health. The study was also supported by South Birmingham Mental Health NHS Trust. In Ireland we would like to acknowledge the generous support of the Wellcome Trust and the Health Research Board, Dublin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kent, L., Doerry, U., Hardy, E. et al. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry 7, 908–912 (2002). https://doi.org/10.1038/sj.mp.4001100
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001100
Keywords
This article is cited by
-
The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment
Molecular Psychiatry (2023)
-
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review
Neurology and Therapy (2022)
-
A three-pronged analysis confirms the association of the serotoninergic system with attention deficit hyperactivity disorder
World Journal of Pediatrics (2022)
-
ADHS im Kindes- und Jugendalter. Update 2020
Pädiatrie & Pädologie (2020)
-
Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder
World Journal of Pediatrics (2019)